Abstract
BackgroundRA leads to high burden on patient (pt) work, functioning and quality of life. Certolizumab pegol (CZP)+MTX improves physical function,1 and workplace and household productivity,2,3 in established and early active...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have